IDH2-mutated acute myeloid leukemia in older adults: prognostic signal is not regimen selection. Comment on: "IDH2 mutation is associated with favorable outcome among older adults with newly diagnosed acute myeloid leukemia treated with hypomethylating agent-based therapy"